|
ACE Mean difference
|
95% CI
|
p-value
|
PO % excess
|
95% CI
|
Adjusted SUCRA % excess
|
Adjusted SUCRA TNH
|
---|
Rank assigned to sexual glands cancer mortality
|
−0.13
|
(−0.28; 0.02)
|
0.093
|
2.26
|
(2.16; 2.35)
|
0.370
|
0.435
|
Rank assigned to thyroid cancer mortality
|
0.19
|
(0.03; 0.35)
|
0.021
|
2.24
|
(2.11; 2.36)
|
0.380
|
0.285
|
Rank assigned to lung cancer mortality
|
−0.06
|
(−0.21; 0.09)
|
0.432
|
1.51
|
(1.39; 1.62)
|
0.745
|
0.775
|
- Abbreviations ACE Average causal effect, 95% CI 95% Confidence Interval, PO % excess Potential outcome under the % excess questionnaire, Adjusted SUCRA Surface under the cumulative ranking curve from the Inverse Probability of Treatment Weighting model